Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis-Reference-Cited by-同舟云学术

Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis

Published:2015-02 Issue:2 Volume:135 Page:553-556.e3
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Harden Jamie L.,Johnson-Huang Leanne M.,Chamian Maria Francesca,Lee Edmund,Pearce Tillman,Leonardi Craig L.,Haider Asifa,Lowes Michelle A.,Krueger James G.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference12 articles.

1. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “type 1” inflammatory gene expression;Lew;Trends Immunol,2004

2. The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-γ, Interleukin-2, and Tumor Necrosis Factor-α, Defining TC1 (Cytotoxic T Lymphocyte) and TH1 Effector Populations:1 a Type 1 Differentiation Bias is also Measured in Circulating Blood T Cells in Psoriatic Patients

3. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response;Uyemura;J Invest Dermatol,1993

4. Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment;Chodorowska;J Eur Acad Dermatol Venereol,1998

5. A potent neutralizing monoclonal antibody can discriminate amongst IFNgamma from various primates with greater specificity than can the human IFNgamma receptor complex;Thakur;Mol Immunol,1999

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Psoriasis Treatment Pipeline;Dermatologic Clinics;2024-07

2. Cytokines in psoriasis: From pathogenesis to targeted therapy;Human Immunology;2024-07

3. Reevaluating the role of interferon‐beta in psoriasis pathogenesis: A registry‐based self‐controlled study;The Journal of Dermatology;2024-06-11

4. Natural Product-Derived Compounds Targeting Keratinocytes and Molecular Pathways in Psoriasis Therapeutics;International Journal of Molecular Sciences;2024-05-31

5. IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy;Frontiers in Immunology;2024-04-15